{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:38:12Z","timestamp":1792730292413,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Invasive meningococcal disease (IMD) is a low-incidence but high-impact infection associated with substantial mortality and sequelae. Following MenACWY vaccine introduction into Argentina\u2019s National Immunization Program in 2017, updated data on residual disease burden are needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A multicenter active hospital-based surveillance study was conducted in 6 pediatric sentinel units in Argentina (January 2020\u2013December 2024) in children younger than 15 years with suspected IMD. Cases were confirmed by culture and\/or polymerase chain reaction from a normally sterile body site. Hospital discharge rates were calculated per 10,000 discharges. Whole-genome sequencing and genetic Meningococcal Antigen Typing System were used to characterize strains and estimate theoretical 4CMenB coverage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Among 234,264 pediatric hospital discharges, 27 confirmed IMD cases were identified (overall rate: 1.2 per 10,000; 95% confidence interval, 0.8\u20131.7). Annual rates showed no consistent pattern between children younger than 2 years and those 2 years or older. The case-fatality rate was 14.8% (4\/27); all deaths occurred in previously healthy children younger than 5 years and were associated with sepsis and a fulminant course (hospital stay \u22641 day). Of 20 cases with a determined capsular group, 19 (95%) were B and 1 (5%) was C; no capsular group Y or W cases were identified. Theoretical 4CMenB coverage by genetic Meningococcal Antigen Typing System was 77.3%, driven by ST-162 clonal complex predominance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>IMD in Argentina continues to predominantly affect young children and is associated with elevated case-fatality amid fulminant sepsis. Serogroup B predominates in the post-MenACWY era, and high estimated 4CMenB coverage supports evaluation of serogroup B vaccination as a complementary prevention strategy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005453","type":"journal-article","created":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:01:22Z","timestamp":1792728082000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Invasive Meningococcal Disease in Hospitalized Children in Argentina, 2020\u20132024"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-7700","authenticated-orcid":false,"given":"Angela","family":"Gentile","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Ricardo Guti\u00e9rrez Children\u2019s Hospital, Buenos Aires City, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bakir","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Ricardo Guti\u00e9rrez Children\u2019s Hospital, Buenos Aires City, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara Noem\u00ed","family":"Maydana","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Sor Ludovica Children\u2019s Hospital, La Plata, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Morales","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Sor Ludovica Children\u2019s Hospital, La Plata, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Ensinck","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Victor Vilela Children\u2019s Hospital, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Ernst","sequence":"additional","affiliation":[{"name":"Clinical Bacteriology Service, Victor Vilela Children\u2019s Hospital, Rosario, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2152-1846","authenticated-orcid":false,"given":"Luciana J","family":"Moreira","sequence":"additional","affiliation":[{"name":"Clinical Bacteriology Service, INEI-ANLIS \u201cDr. Carlos G. Malbr\u00e1n,\u201d Buenos Aires City, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9815-4985","authenticated-orcid":false,"given":"Pablo Andr\u00e9s","family":"Melonari","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Humberto Notti Pediatric Hospital, Mendoza, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Santill\u00e1n Iturres","sequence":"additional","affiliation":[{"name":"Infectious Diseases Service, Eva Per\u00f3n Children\u2019s Hospital, Catamarca, Argentina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Efron","sequence":"additional","affiliation":[{"name":"Clinical Bacteriology Service, INEI-ANLIS \u201cDr. Carlos G. Malbr\u00e1n,\u201d Buenos Aires City, Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,23]]},"reference":[{"key":"R2-20261023","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","article-title":"Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers.","volume":"7","author":"Olbrich","year":"2018","journal-title":"Infect Dis Ther"},{"key":"R3-20261023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/14760584.2019.1557520","article-title":"The global meningococcal initiative meeting on prevention of meningococcal disease worldwide: epidemiology, surveillance, hypervirulent strains, antibiotic resistance and high-risk populations.","volume":"18","author":"Acevedo","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"R4-20261023","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijid.2019.05.006","article-title":"Epidemiological burden of meningococcal disease in Latin America: a systematic literature review.","volume":"85","author":"Vespa Presa","year":"2019","journal-title":"Int J Infect Dis"},{"key":"R5-20261023","doi-asserted-by":"crossref","first-page":"2237391","DOI":"10.1080\/21645515.2023.2237391","article-title":"Meningococcal burden of disease in Argentina: 10 years epidemiologic review.","volume":"19","author":"Neyro","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"R7-20261023","doi-asserted-by":"crossref","first-page":"e44102","DOI":"10.1371\/journal.pone.0044102","article-title":"Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010.","volume":"7","author":"Ibarz-Pavon","year":"2012","journal-title":"PLoS One"},{"key":"R8-20261023","doi-asserted-by":"crossref","first-page":"e58065","DOI":"10.1371\/journal.pone.0058065","article-title":"Phenotypic and genotypic characteristics of Neisseria meningitidis disease-causing strains in Argentina, 2010.","volume":"8","author":"Sorhouet-Pereira","year":"2013","journal-title":"PLoS One"},{"key":"R9-20261023","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jinf.2008.07.014","article-title":"High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11 clone in Southern Brazil.","volume":"57","author":"Weidlich","year":"2008","journal-title":"J Infect"},{"key":"R10-20261023","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3201\/eid2102.140746","article-title":"Neisseria meningitidis ST-11 clonal complex, Chile 2012.","volume":"21","author":"Araya","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"R12-20261023","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/INF.0000000000001429","article-title":"Meningococcal disease in children in Argentina a 3-year active sentinel hospital surveillance study.","volume":"36","author":"Gentile","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20261023","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fped.2018.00321","article-title":"Invasive meningococcal disease in the vaccine era.","volume":"6","author":"Nadel","year":"2018","journal-title":"Front Pediatr"},{"key":"R14-20261023","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination.","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"key":"R15-20261023","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.vaccine.2021.11.075","article-title":"Invasive meningococcal disease in Chile seven years after ACWY conjugate vaccine introduction.","volume":"40","author":"Villena","year":"2022","journal-title":"Vaccine"},{"key":"R18-20261023","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1017\/S0950268819002024","article-title":"Estimation of the real burden of invasive meningococcal disease in Argentina.","volume":"147","author":"G\u00f3mez","year":"2019","journal-title":"Epidemiol Infect"},{"key":"R19-20261023","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R21-20261023","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1586\/14760584.2013.814879","article-title":"The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative.","volume":"12","author":"S\u00e1fadi","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"R23-20261023","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/JCM.38.2.855-857.2000","article-title":"Simultaneous approach for nonculture PCR-based identification and serogroup prediction of Neisseria meningitidis.","volume":"38","author":"Taha","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R24-20261023","doi-asserted-by":"crossref","first-page":"e1005595","DOI":"10.1371\/journal.pcbi.1005595","article-title":"Unicycler: resolving bacterial genome assemblies from short and long sequencing reads.","volume":"13","author":"Wick","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"R25-20261023","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications.","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res"},{"key":"R26-20261023","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.vaccine.2018.12.061","article-title":"Genetic meningococcal antigen typing system (gMATS): a genotyping tool that predicts 4CMenB strain coverage worldwide.","volume":"37","author":"Muzzi","year":"2019","journal-title":"Vaccine"},{"key":"R27-20261023","doi-asserted-by":"crossref","first-page":"e20675","DOI":"10.1371\/journal.pone.0020675","article-title":"Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in S\u00e3o Paulo, Brazil.","volume":"6","author":"Sacchi","year":"2011","journal-title":"PLoS One"},{"key":"R29-20261023","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","article-title":"Clinical recognition of meningococcal disease in children and adolescents.","volume":"367","author":"Thompson","year":"2006","journal-title":"Lancet"},{"key":"R30-20261023","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3390\/vaccines11121841","article-title":"Epidemiology of meningococcal disease in four South American countries and rationale of vaccination in adolescents from the region: position paper of the Latin American Society of Pediatric Infectious Diseases (SLIPE).","volume":"11","author":"Villena","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"R33-20261023","first-page":"40","article-title":"Phenotypic and genomic surveillance of invasive Neisseria meningitidis isolates in Argentina (2015-2022): clonal structure and vaccine implications.","volume":"58","author":"Efron","year":"2026","journal-title":"Rev Argent Microbiol"},{"key":"R34-20261023","doi-asserted-by":"crossref","first-page":"e0150721","DOI":"10.1371\/journal.pone.0150721","article-title":"Predicted strain coverage of a new meningococcal multicomponent vaccine (4CMenB) in Spain: analysis of the differences with other European countries.","volume":"11","author":"Abad","year":"2016","journal-title":"PLoS One"},{"key":"R35-20261023","doi-asserted-by":"crossref","first-page":"2378537","DOI":"10.1080\/21645515.2024.2378537","article-title":"Genetic characterization and estimated 4CMenB vaccine strain coverage of 284 Neisseria meningitidis isolates causing invasive meningococcal disease in Argentina in 2010-2014.","volume":"20","author":"Efron","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"R36-20261023","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","article-title":"Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data.","volume":"3","author":"Brueggemann","year":"2021","journal-title":"Lancet Digit Health"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:01:25Z","timestamp":1792728085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/INF.0000000000005453"}},"subtitle":["Clinical, Epidemiologic and Molecular Findings From a Multicenter Active Surveillance Study"],"short-title":[],"issued":{"date-parts":[[2026,10,23]]},"references-count":26,"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005453","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,23]]},"assertion":[{"value":"2026-05-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}